Gonadoblastoma in androgen insensitivity syndrome: A case report

Tumori

Volumn 89, Issue 2, 2003, Pages 196-198

  Raspaglies, Francesco ^a   Ditto, Antonino ^a   Cobellis, Luigi ^a   Quattrone, Pasquale ^a   Fontanelli, Rosanna ^a   Kusamura, Shigeki ^a   Solima, Eugenio ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Androgen insensitivity syndrome; Cytogenetic analysis; Gonadoblastoma; Treatment

Indexed keywords

BLEOMYCIN; ETOPOSIDE; PLATINUM;

ADULT; ANDROGEN INSENSITIVITY SYNDROME; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; CYTOGENETICS; DYSGERMINOMA; FEMALE; GONADOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INHERITANCE; LAPAROTOMY; MALE PSEUDOHERMAPHRODITISM; PHENOTYPE; PHYSICAL EXAMINATION; TESTIS; TREATMENT OUTCOME; VAGINA;

EID: 0038207076     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160308900218     Document Type: Article

References (17)

1. Morris J: The syndrome of testicular feminization in male pseudohermaphrodites. Am J Obstet Gynecol, 65: 1192, 1953.
2. Rutgers JL, Scully RE: The androgen insensivity syndrome (testicular feminization): a clinicopathologic study of 43 cases. Int J Gynecol Pathol, 10: 126-144, 1991.
3. Chen CP, Chen SR, Wang TY, Wang W, Hwu YM: A frameshift mutation in the DNA-binding domain of the androgen receptor gene associated with complete androgen insensitivity, persistent mullerian structures, and germ cell tumors in dysgenetic gonads. Fertil Steril, 72: 170-173, 1999.
4. Brinkmann AO: Molecular basis of androgen insensitivity. Mol Cell Endocrinol, 179: 105-109, 2001.
5. Nitsche EM, Hiort O: The molecular basis of androgen insensitivity. Horm Res, 54: 327-333, 2000.
6. Rosa S, Biason-Lauber A, Mongan NP, Navratil F, Schoenle EJ: Complete androgen insensitivity syndrome caused by a novel mutation in the ligand-binding domain of the androgen receptor: functional characterization. J Clin Endocrinol Metab, 87: 4378-4382, 2002.
7. Zenteno JC, Chavez B, Vilchis F, Kofman-Alfaro S: Phenotypic heterogeneity associated with identical mutations in residue 870 of the androgen receptor. Horm Res, 57: 90-93, 2002.
8. Lewis ACW: Chromosomal aspect of primary amenorrhea. Proc R Soc Med, 63: 297-298, 1970.
9. Lukusa T, Fryns JP, Kleczkowska A, Van den Berghe H: Role of gonadal dysgenesis in gonadoblastoma induction in 46, XY individuals. The Leuven experience in 46, XY pure gonadal dysgenesis and testicular feminization syndromes. Genet Couns, 2: 9-16, 1991.
10. rd ed, Rimoin DL, Connor JM, Pyretz RE (Eds), pp 1477-1500, Churchill Livingston, New York, 1997.
11. Verp MS, Simpson JL: Abnormal sexual differentiation and neoplasia. Cancer Genet Cytogenet, 25: 191-218, 1987.
12. Muller J, Skakkebaek N: Testicular carcinoma in situ in children with the androgen insensitivity (testicular feminisation) syndrome. Br Med J, 288: 1419-1420, 1984.
13. Scully RE: Gonadoblastoma. A gonadal tumor related to dysgerminoma (seminoma) and capable of sex-hormone production. Cancer, 6: 445-462, 1953.
14. Troche V, Hernandez E: Neoplasia arising in dysgenetic gonads. Obstet Gynecol Surv, 41: 74-79, 1986.
15. Scully RE: Gonadoblastoma. A review of 74 cases. Cancer, 25: 1340-1356, 1970.
16. Manuel M, Katoyama P, Jones HW: The age of occurrence of gonadal tumors in intersex patients with a Y cromosome. Am J Obstet Gynecol, 124: 293, 1976.
17. Dewhurst CJ, Ferreire HP, Gillet PG: Gonadal malignancy in XY females. J Ob Gyn Br Commonwealth, 78: 1017, 1971.